Andrew A. Hindman's Net Worth
$7.39 Million
Who is Andrew A. Hindman?
Andrew A. Hindman has an estimated net worth of $7.39 Million. This is based on reported shares across multiple companies, which include Theravance Biopharma, Inc., and ACORDA THERAPEUTICS INC.
SEC CIK
Andrew A. Hindman's CIK is 0001607965
Past Insider Trading and Trends
2014 was Andrew A. Hindman's most active year for acquiring shares with 5 total transactions. Andrew A. Hindman's most active month to acquire stocks was the month of February. 2022 was Andrew A. Hindman's most active year for disposing of shares, totalling 5 transactions. Andrew A. Hindman's most active month to dispose stocks was the month of April. 2021 saw Andrew A. Hindman paying a total of $0.00 for 405,000 shares, this is the most they've acquired in one year. In 2018 Andrew A. Hindman cashed out on 48,177 shares for a total of $1,163,006.09, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.82
SVP, CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -18.97% | -90.06K |
$10.97 | -$988,109.95 | 384.71K |
Nov 18 - Nov 20
| |||
Form 4
| -5.14% | -25.68K |
$9.34 | -$239,813.84 | 473.51K |
Aug 19
| |||
Form 4
| +4.17% | 20K |
—
|
—
| 499.18K |
Jul 25
| |||
Form 4
| -0.70% | -3.37K |
$8.74 | -$29,410.10 | 479.18K |
May 20
| |||
Form 4
| -5.12% | -25.97K |
$9.61 | -$249,600.53 | 481.29K |
Feb 18
| |||
Form 4
| +203.28% | 340K |
—
|
—
| 507.26K |
Dec 2
| |||
Form 4
| -0.80% | -1.35K |
$8.36 | -$11,286.00 | 167.26K |
Nov 19
| |||
Form 4
| -9.45% | -17.46K |
$14.05 | -$245,369.20 | 167.38K |
Aug 20
| |||
Form 4
| -0.51% | -942.00 |
$17.80 | -$16,767.60 | 184.84K |
May 20
| |||
Form 4
| -2.11% | -3.98K |
$18.79 | -$74,859.36 | 184.7K |
Feb 20
| |||
Form 4
| +52.55% | 65K |
—
|
—
| 188.69K |
Feb 8
| |||
Form 4
| -3.39% | -4.32K |
$18.22 | -$78,765.06 | 123.14K |
Aug 20
| |||
Form 4
| +18.61% | 20K |
—
|
—
| 127.46K |
Jul 27
| |||
Form 4
| -6.22% | -7.06K |
$25.90 | -$182,854.00 | 106.49K |
Feb 20
| |||
Form 4
| +127.10% | 63.55K |
—
|
—
| 113.55K |
Feb 3
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACORDA THERAPEUTICS INC (ACOR) Snapshot price: $17.49
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +137.17% | 9.04K |
—
|
—
| 15.64K |
Mar 8
| |||
Form 4
| -11.74% | -877.00 |
$13.38 | -$11,734.26 | 6.59K |
Feb 21
| |||
Form 4
| +44.48% | 2.3K |
—
|
—
| 7.47K |
Dec 22
| |||
Form 4
| -12.71% | -753.00 |
$20.56 | -$15,478.37 | 5.17K |
Scheduled
|
Dec 3
| ||
Form 4
| -12.92% | -879.00 |
$20.28 | -$17,826.12 | 5.92K |
Nov 5
| |||
Form 4
| +51.08% | 2.3K |
—
|
—
| 6.8K |
Sep 10
| |||
Form 4
| -90.44% | -42.62K |
$24.26 | -$1,034,006.10 | 4.5K |
May 25
| |||
Form 4
| -7.70% | -3.93K |
$24.35 | -$95,695.50 | 47.12K |
May 13
| |||
Form 4
| +12.67% | 5.74K |
—
|
—
| 51.05K |
Feb 22
| |||
Form 4
| -1.77% | -817.00 |
$20.54 | -$16,784.12 | 45.31K |
Scheduled
|
Dec 1
| ||
Form 4
| -14.31% | -7.70K |
$15.75 | -$121,318.74 | 46.12K |
Scheduled
|
May 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +9.34% | 4.6K |
—
|
—
| 53.83K |
Mar 1
| |||
Form 4
| -0.89% | -443.00 |
$20.72 | -$9,180.07 | 49.23K |
Scheduled
|
Dec 1
| ||
Form 4
| -8.91% | -4.86K |
$26.11 | -$126,884.88 | 49.67K |
Scheduled
|
May 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
| -0.80% | -442.00 |
$38.26 | -$16,910.92 | 54.53K |
Scheduled
|
Dec 1
| ||
Form 4
| -8.00% | -4.78K |
$29.82 | -$142,493.52 | 54.97K |
Scheduled
|
May 13 - May 15
| ||
Form 4
| +7.59% | 4.21K |
—
|
—
| 59.75K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
∞
| 55.54K |
—
|
—
| 55.54K |
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||